Calumet Inc [CLMT] stock was sold by Morical Gregory J at the price of US$0.42 million

Calumet Inc’s recently made public that its SVP, GENERAL COUNSEL Morical Gregory J unloaded Company’s shares for reported $0.42 million on Jun 16 ’25. In the deal valued at $16.69 per share,25,123 shares were sold. As a result of this transaction, Morical Gregory J now holds 39,415 shares worth roughly $0.66 million.

Then, Straumins Jennifer sold 100,000 shares, generating $1,623,000 in total proceeds. Upon selling the shares at $16.23, the Director now owns 934,589 shares.

Before that, Straumins Jennifer sold 50,000 shares. Calumet Inc shares valued at $754,000 were divested by the Director at a price of $15.08 per share. As a result of the transaction, Straumins Jennifer now holds 1,034,589 shares, worth roughly $17.44 million.

BofA Securities initiated its Calumet Inc [CLMT] rating to a Buy in a research note published on May 13, 2025; the price target was $15. A number of analysts have revised their coverage, including UBS’s analysts, who increased its forecast for the stock in mid March from “a Sell” to “a Neutral”. TD Cowen also remained covering CLMT and has decreased its forecast on March 04, 2025 with a “Hold” recommendation from previously “Buy” rating. UBS revised its rating on February 04, 2025. It rated CLMT as “a Sell” which previously was an “a Neutral”.

Price Performance Review of CLMT

On Monday, Calumet Inc [NASDAQ:CLMT] saw its stock jump 11.43% to $16.86. Over the last five days, the stock has gained 28.02%. Calumet Inc shares have fallen nearly -23.43% since the year began. Nevertheless, the stocks have risen 2.18% over the past one year. While a 52-week high of $25.29 was reached on 01/06/25, a 52-week low of $7.68 was recorded on 04/09/25.

Levels Of Support And Resistance For CLMT Stock

The 24-hour chart illustrates a support level at 15.95, which if violated will result in even more drops to 15.05. On the upside, there is a resistance level at 17.38. A further resistance level may holdings at 17.91.

The most recent change occurred on November 11, 2024 when TD Cowen resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $26.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.